TestDynamics, a medical imaging AI company, raised $9 million in Series A funding. Healthier Capital led the round. Cedars-Sinai Technology Ventures also participated.
Funding plans
The company plans to grow its clinical validation team that benchmarks algorithms against ground truth. It will deploy across more health systems. It will also extend Satori into new imaging subspecialties.
Current use
Satori is already in clinical use at several top ten U.S. medical centers. TestDynamics, based in Austin, Texas, describes its approach as Amalgamated Intelligence. The method combines outputs from competing algorithms into one result.
What Satori does
Satori is a vendor-neutral platform above imaging AI tools. It continuously measures how each algorithm performs on real cases. It gives radiologists one prioritized read inside their existing workflow.
A 2024 Nature Medicine analysis found 43% of FDA-authorized AI and ML devices lacked published clinical validation data. Radiology accounts for about three-quarters of recent clearances. TestDynamics offers Satori as an independent layer to evaluate these tools.